Structure of the SARS-CoV-2 Nucleocapsid: building block to viral capsid
SARS-CoV-2 核衣壳的结构:病毒衣壳的构建模块
基本信息
- 批准号:10728253
- 负责人:
- 金额:$ 28.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-05 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:2019-nCoVAddressAffinityAntibodiesBacterial RNABiochemicalBiological AssayCapsidCellsComplementComplexCoronavirusCryoelectron MicroscopyDataDiameterDimerizationDiseaseElectron MicroscopyElectrophoretic Mobility Shift AssayExclusionFamilyGenetic TranscriptionGenomeGoalsHandHistonesIn VitroIndividualLabelLengthMapsMass Spectrum AnalysisMediatingMedicineModelingMolecularMolecular ConformationMolecular MachinesNucleocapsidNucleocapsid ProteinsPlayPolymersPositioning AttributeProcessProteinsRNARNA BindingRNA Recognition MotifRNA VirusesRNA chemical synthesisRNA-Protein InteractionResolutionRoleSARS-CoV-2 genomeSARS-CoV-2 inhibitorSARS-CoV-2 variantSiteStructural ProteinStructureSystemViralViral Structural ProteinsVirionVirusVirus AssemblyVisualizationWorkantiviral drug developmentcoronavirus antiviralcrosslinkdensitydimerflexibilityinnovationpandemic diseaseparticlepolymerizationrational designreconstitutionscreeningself organizationstemstoichiometrystructural biologyvariants of concernviral RNA
项目摘要
SARS-CoV-2, the causative agent of an unprecedented global pandemic, has just four structural proteins. Of these, the nucleocapsid N is the most abundant protein in the virion, and plays essential roles in genome encapsidation and viral assembly. However, N has thus far defied structure determination of its full-length molecule. Indeed, there are currently no high-resolution structures of full-length N for any coronavirus, although multiple structures exist for individual domains within N. The lack of structural information on N, its assembly and its interactions and encapsidation of the genome stem from the inherent flexibility contributed by three intrinsically disordered regions. In previous work, N, in the absence of RNA or in the presence of random bacterial RNA derived from the expression system, was too flexible to allow determination of a high-resolution structure. The assembled capsid in the virion is also too heterogeneous in its flexibility, positions and conformations to afford high-resolution information. Through careful analysis using electromobility shift assays, size-exclusion and screening by electron microscopy, we have now identified portions of the SARS-CoV-2 genome that yield structurally homogeneous, purified N dimers, octamers, and 16-mers that are amenable to high-resolution structural analysis, and which represent the basic building block and likely assembly intermediates of the full capsid. We have further produced a polymerized full-length capsid in vitro that is also amenable to structural study. Here we propose cryoEM of the dimer, assembly intermediates and full length in vitro capsid, complemented by innovative native mass spectrometry and straightforward specific antibody-mediated domain identification. This work will illuminate (i) the structure and assembly of the coronavirus capsid; (ii) how the RNA genome interacts with multiple domains of the full- length N and connects along polymerized copies of N; (iii) conformational adjustments that occur in assembly, protein-protein and protein-RNA interaction sites; and (iv) sites that may be amenable targets for antiviral development.
SARS-CoV-2 是史无前例的全球大流行病的病原体,只有四种结构蛋白。其中,核衣壳 N 是病毒体中最丰富的蛋白质,在基因组衣壳化和病毒组装中发挥重要作用。然而,N 迄今为止仍无法确定其全长分子的结构。事实上,目前任何冠状病毒都没有全长 N 的高分辨率结构,尽管 N 内的各个结构域存在多种结构。N、其组装、相互作用以及基因组衣壳化的结构信息的缺乏源于由三个本质上无序的区域贡献的固有灵活性。在之前的工作中,在不存在 RNA 或存在来自表达系统的随机细菌 RNA 的情况下,N 过于灵活,无法确定高分辨率结构。病毒粒子中组装的衣壳在灵活性、位置和构象方面也过于异质,无法提供高分辨率信息。通过使用电动迁移率测定、尺寸排除和电子显微镜筛选进行仔细分析,我们现在已经鉴定出 SARS-CoV-2 基因组的部分,这些部分产生结构均质的、纯化的 N 二聚体、八聚体和 16 聚体,这些聚体适合高-分辨率结构分析,代表完整衣壳的基本构建块和可能的组装中间体。我们进一步在体外制备了聚合的全长衣壳,该衣壳也适合结构研究。在这里,我们建议对二聚体、组装中间体和全长体外衣壳进行冷冻电镜分析,并辅以创新的天然质谱分析和直接的特异性抗体介导的结构域鉴定。这项工作将阐明(i)冠状病毒衣壳的结构和组装; (ii) RNA基因组如何与全长N的多个结构域相互作用并沿着N的聚合拷贝连接; (iii) 组装、蛋白质-蛋白质和蛋白质-RNA 相互作用位点发生的构象调整; (iv) 可能成为抗病毒开发目标的位点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Erica Ollmann Saphire其他文献
Oxidation-sensitive polymersomes as vaccine nanocarriers enhance humoral responses against Lassa virus envelope glycoprotein.
氧化敏感聚合物囊泡作为疫苗纳米载体可增强针对拉沙病毒包膜糖蛋白的体液反应。
- DOI:
- 发表时间:
2017 - 期刊:
- 影响因子:3.7
- 作者:
Clara Galan;M. Rincon;G. Zimmer;Erica Ollmann Saphire;J. Hubbell;Sachiko Hirosue;M. Swartz;S. Kunz - 通讯作者:
S. Kunz
Achieving cross-reactivity with pan-ebolavirus antibodies.
实现与泛埃博拉病毒抗体的交叉反应。
- DOI:
10.1016/j.coviro.2019.01.003 - 发表时间:
2019-02-01 - 期刊:
- 影响因子:0
- 作者:
L. King;J. Milligan;B. R. West;S. Schendel;Erica Ollmann Saphire - 通讯作者:
Erica Ollmann Saphire
A Vaccine against Ebola Virus
埃博拉病毒疫苗
- DOI:
10.1016/j.cell.2020.03.011 - 发表时间:
2020-04-01 - 期刊:
- 影响因子:64.5
- 作者:
Erica Ollmann Saphire - 通讯作者:
Erica Ollmann Saphire
Recurring conformation of the human immunodeficiency virus type 1 gp120 V3 loop.
人类免疫缺陷病毒 1 型 gp120 V3 环的重复构象。
- DOI:
10.1016/s0042-6822(03)00525-7 - 发表时间:
2003-10-10 - 期刊:
- 影响因子:3.7
- 作者:
R. Stanfield;J. Ghiara;Erica Ollmann Saphire;A. Profy;I. Wilson - 通讯作者:
I. Wilson
Fine Mapping of the Interaction of Neutralizing and Nonneutralizing Monoclonal Antibodies with the CD4 Binding Site of Human Immunodeficiency Virus Type 1 gp120
中和性和非中和性单克隆抗体与人类免疫缺陷病毒 1 型 gp120 的 CD4 结合位点相互作用的精细图谱
- DOI:
- 发表时间:
2003 - 期刊:
- 影响因子:5.4
- 作者:
R. Pantophlet;Erica Ollmann Saphire;P. Poignard;P. Parren;I. Wilson;D. Burton - 通讯作者:
D. Burton
Erica Ollmann Saphire的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Erica Ollmann Saphire', 18)}}的其他基金
Consortium for Immunotherapeutics against Emerging Viral Threats
针对新兴病毒威胁的免疫治疗联盟
- 批准号:
10447562 - 财政年份:2021
- 资助金额:
$ 28.59万 - 项目类别:
Consortium for Immunotherapeutics against Emerging Viral Threats
针对新兴病毒威胁的免疫治疗联盟
- 批准号:
10199909 - 财政年份:2020
- 资助金额:
$ 28.59万 - 项目类别:
Specific and Broadly Active Monoclonal Antibody Therapeutics Against The Filoviruses
针对丝状病毒的特异性且广泛活性的单克隆抗体疗法
- 批准号:
10158448 - 财政年份:2019
- 资助金额:
$ 28.59万 - 项目类别:
Consortium for Immunotherapeutics against Emerging Viral Threats
针对新兴病毒威胁的免疫治疗联盟
- 批准号:
10402336 - 财政年份:2019
- 资助金额:
$ 28.59万 - 项目类别:
Consortium for Immunotherapeutics against Emerging Viral Threats
针对新兴病毒威胁的免疫治疗联盟
- 批准号:
10617733 - 财政年份:2019
- 资助金额:
$ 28.59万 - 项目类别:
Consortium for Immunotherapeutics against Emerging Viral Threats
针对新兴病毒威胁的免疫治疗联盟
- 批准号:
10158446 - 财政年份:2019
- 资助金额:
$ 28.59万 - 项目类别:
Consortium for Immunotherapeutics against Emerging Viral Threats
针对新兴病毒威胁的免疫治疗联盟
- 批准号:
9924443 - 财政年份:2019
- 资助金额:
$ 28.59万 - 项目类别:
相似国自然基金
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Structure-based computational engineering of saCas9 PAM requirement
saCas9 PAM 要求的基于结构的计算工程
- 批准号:
10696610 - 财政年份:2023
- 资助金额:
$ 28.59万 - 项目类别:
GMP manufacturing and IND Filing of IN-002, a potent inhaled muco-trapping antibody therapy for Respiratory Syncytial Virus
IN-002 的 GMP 生产和 IND 备案,这是一种针对呼吸道合胞病毒的有效吸入粘液捕获抗体疗法
- 批准号:
10761398 - 财政年份:2023
- 资助金额:
$ 28.59万 - 项目类别:
Multidimensional antibody engineering to enhance the potency and breadth of a betacoronavirus medical countermeasure
多维抗体工程可增强β冠状病毒医学对策的效力和广度
- 批准号:
10699866 - 财政年份:2023
- 资助金额:
$ 28.59万 - 项目类别:
Understanding antibody responses and defining correlates of protection for endemic and pandemic coronavirus strains
了解抗体反应并定义地方性和大流行性冠状病毒株保护的相关性
- 批准号:
10549479 - 财政年份:2023
- 资助金额:
$ 28.59万 - 项目类别:
An L-Aptamer-Displacement Assay for High-Throughput Screening of RNA-Targeted Small Molecule Antivirals
用于高通量筛选 RNA 靶向小分子抗病毒药物的 L 适体置换测定
- 批准号:
10648368 - 财政年份:2023
- 资助金额:
$ 28.59万 - 项目类别: